ROCK I/II inhibitors (Arizona State University)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameROCK I/II inhibitors (Arizona State University)
Drug Alias NameT-343
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRho-associated protein kinase 1 inhibitorsRho-associated protein kinase 2 inhibitors
TargetsRho-associated protein kinase 1Rho-associated protein kinase 2
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArizona State University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArizona State UniversityTranslational Genomics Research Institute
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A